# Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy

> **NCT07289087** · — · NOT_YET_RECRUITING · sponsor: **Associazione Qol-one** · enrollment: 162 (estimated)

## Conditions studied

- Quality of Life
- Patient Reported Outcome (PRO)
- Allogeneic Blood and Marrow Transplantation (BMT)
- CAR T Cell Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07289087
- **Lead sponsor:** Associazione Qol-one
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07289087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07289087, "Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07289087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*